15. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie
20.11. - 21.11.2008, Bonn
Pharmacovigilance and risk management
Meeting Abstract
(08gaa10)
[Volltext]
Identification of drugs causing Blood Dyscrasias, Hepatitis and Pancreatitis – Outcomes of the Case-Control Surveillance Study from the National Pharmacovigilance-Center Berlin (PVZ-FAKOS)
Thomae M, Bronder E, Andersohn F, Klimpel A, Garbe E[Volltext]
Meeting Abstract
(08gaa11)
[Volltext]
Sex-differences in the rate of adverse drug reactions associated with diuretics
Thürmann P, Janhsen K, Werner U, Szymanski J, Müller S, Drewelow B, Farker K, Hippius M, Siegmund W, May K, Glaeske G, Rottenkolber M, Hasford J[Volltext]
Meeting Abstract
(08gaa12)
[Volltext]
Pharmacovigilance and Patient Safety – Results of the German Net of Regional Pharmacovigilance Centers
Schmiedl S, Hasford J, Rottenkolber M, Szymanski J, Drewelow B, Mueller S, Haase G, Siegmund W, May H, Hippius M, Farker K, Gruca D, Guenther IR, Thuermann PA[Volltext]
Meeting Abstract
(08gaa13)
[Volltext]
Signal generation in the database of the German Net of Regional Pharmacovigilance Centers
Rottenkolber M, Hasford J[Volltext]
Meeting Abstract
(08gaa14)
[Volltext]
Adverse drug reactions and potentially inappropriate medication for the elderly
Thürmann PA, Rottenkolber M, Schmiedl S, Müller S, Drewelow B, Farker K, Hippius M, Siegmund W, May K, Hasford J[Volltext]
Meeting Abstract
(08gaa15)
[Volltext]
Educational Intervention and Monitoring Programme to Improve Physician Reporting of Adverse Drug Reactions (ADRs) in a Primary Care Setting
Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, Matthes H[Volltext]
Meeting Abstract
(08gaa16)
[Volltext]
Impact of risk communications and market withdrawals on prescribing of cyclooxygenase-2 inhibitors and non-selective nonsteroidal anti-inflammatory drugs
Czeche S, Quinzler R, Schüssel K, Feldt S, Klöckner D, Schulz M[Volltext]
